1. Home
  2. ERJ vs RGEN Comparison

ERJ vs RGEN Comparison

Compare ERJ & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ERJ
  • RGEN
  • Stock Information
  • Founded
  • ERJ 1969
  • RGEN 1981
  • Country
  • ERJ Brazil
  • RGEN United States
  • Employees
  • ERJ N/A
  • RGEN N/A
  • Industry
  • ERJ Aerospace
  • RGEN Medical/Dental Instruments
  • Sector
  • ERJ Industrials
  • RGEN Health Care
  • Exchange
  • ERJ Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • ERJ 8.6B
  • RGEN 8.0B
  • IPO Year
  • ERJ 2000
  • RGEN N/A
  • Fundamental
  • Price
  • ERJ $48.81
  • RGEN $126.50
  • Analyst Decision
  • ERJ Buy
  • RGEN Buy
  • Analyst Count
  • ERJ 5
  • RGEN 12
  • Target Price
  • ERJ $48.75
  • RGEN $172.67
  • AVG Volume (30 Days)
  • ERJ 1.1M
  • RGEN 815.5K
  • Earning Date
  • ERJ 05-06-2025
  • RGEN 04-29-2025
  • Dividend Yield
  • ERJ 0.10%
  • RGEN N/A
  • EPS Growth
  • ERJ 70.71
  • RGEN N/A
  • EPS
  • ERJ 0.52
  • RGEN N/A
  • Revenue
  • ERJ $6,519,769,233.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • ERJ N/A
  • RGEN $13.93
  • Revenue Next Year
  • ERJ $13.68
  • RGEN $14.35
  • P/E Ratio
  • ERJ $92.53
  • RGEN N/A
  • Revenue Growth
  • ERJ 39.31
  • RGEN 4.88
  • 52 Week Low
  • ERJ $25.24
  • RGEN $102.97
  • 52 Week High
  • ERJ $56.61
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • ERJ 59.43
  • RGEN 44.61
  • Support Level
  • ERJ $46.85
  • RGEN $123.10
  • Resistance Level
  • ERJ $50.45
  • RGEN $135.47
  • Average True Range (ATR)
  • ERJ 1.44
  • RGEN 6.98
  • MACD
  • ERJ 0.38
  • RGEN -0.97
  • Stochastic Oscillator
  • ERJ 75.34
  • RGEN 25.20

About ERJ Embraer S.A.

Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: